ZD6474 is a VEGF-signalling inhibitor that has demonstrated broad-spectrum activity in established tumour xenograft models, with chronic, once-daily oral administration producing significant growth delays at doses of 25 mg kg−1 day−1 or less (Wedge et al, 2002). The gene discussed is VEGFA; the disease is neoplasm.